In vivo evaluation of riboflavin receptor targeted fluorescent USPIO in mice with prostate cancer xenografts

Riboflavin (Rf) receptors bind and translocate Rf and its phosphorylated forms (e.g. flavin mononucleotide, FMN) into cells where they mediate various cellular metabolic pathways. Previously, we showed that FMN-coated ultrasmall superparamagnetic iron oxide (FLUSPIO) nanoparticles are suitable for l...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jayapaul, Jabadurai (VerfasserIn) , Arns, Susanne (VerfasserIn) , Bunker, Matt (VerfasserIn) , Weiler, Marek (VerfasserIn) , Rutherford, Sandra (VerfasserIn) , Comba, Peter (VerfasserIn) , Kiessling, Fabian (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 29 September 2016
In: Nano research
Year: 2016, Jahrgang: 9, Heft: 5, Pages: 1319-1333
ISSN:1998-0000
DOI:10.1007/s12274-016-1028-7
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s12274-016-1028-7
Volltext
Verfasserangaben:Jabadurai Jayapaul, Susanne Arns, Matt Bunker, Marek Weiler, Sandra Rutherford, Peter Comba and Fabian Kiessling

MARC

LEADER 00000caa a2200000 c 4500
001 1696979277
003 DE-627
005 20230427121951.0
007 cr uuu---uuuuu
008 200430s2016 xx |||||o 00| ||eng c
024 7 |a 10.1007/s12274-016-1028-7  |2 doi 
035 |a (DE-627)1696979277 
035 |a (DE-599)KXP1696979277 
035 |a (OCoLC)1341318038 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Jayapaul, Jabadurai  |e VerfasserIn  |0 (DE-588)1017964955  |0 (DE-627)690476892  |0 (DE-576)354712551  |4 aut 
245 1 0 |a In vivo evaluation of riboflavin receptor targeted fluorescent USPIO in mice with prostate cancer xenografts  |c Jabadurai Jayapaul, Susanne Arns, Matt Bunker, Marek Weiler, Sandra Rutherford, Peter Comba and Fabian Kiessling 
264 1 |c 29 September 2016 
300 |b Illustrationen 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 30.04.2020 
520 |a Riboflavin (Rf) receptors bind and translocate Rf and its phosphorylated forms (e.g. flavin mononucleotide, FMN) into cells where they mediate various cellular metabolic pathways. Previously, we showed that FMN-coated ultrasmall superparamagnetic iron oxide (FLUSPIO) nanoparticles are suitable for labeling metabolically active cancer and endothelial cells in vitro. In this study, we focused on the in vivo application of FLUSPIO using prostate cancer xenografts. Size, charge, and chemical composition of FLUSPIO were evaluated. We explored the in vitro specificity of FLUSPIO for its cellular receptors using magnetic resonance imaging (MRI) and Prussian blue staining. Competitive binding experiments were performed in vivo by injecting free FMN in excess. Bio-distribution of FLUSPIO was determined by estimating iron content in organs and tumors using a colorimetric assay. AFM analysis and zeta potential measurements revealed a particulate morphology approximately 20-40 nm in size and a negative zeta potential (-24.23 ± 0.15 mV) in water. X-ray photoelectron spectroscopy and time-of-flight secondary ion mass spectrometry data confirmed FMN present on the USPIO nanoparticle surface. FLUSPIO uptake in prostate cancer cells and human umbilical vein endothelial cells was significantly higher than that of control USPIO, while addition of excess of free FMN reduced accumulation. Similarly, in vivo MRI and histology showed specific FLUSPIO uptake by prostate cancer cells, tumor endothelial cells, and tumor-associated macrophages. Besides prominent tumor accumulation, FLUSPIO accumulated in the liver, spleen, lung, and skin. Hence, our data strengthen our hypothesis that targeting riboflavin receptors is an efficient approach to accumulate nanomedicines in tumors opening perspectives for the development of diagnostic and therapeutic systems. 
700 1 |a Arns, Susanne  |e VerfasserIn  |4 aut 
700 1 |a Bunker, Matt  |e VerfasserIn  |4 aut 
700 1 |a Weiler, Marek  |e VerfasserIn  |4 aut 
700 1 |a Rutherford, Sandra  |e VerfasserIn  |4 aut 
700 1 |a Comba, Peter  |d 1953-  |e VerfasserIn  |0 (DE-588)122976843  |0 (DE-627)082271712  |0 (DE-576)160608988  |4 aut 
700 1 |a Kiessling, Fabian  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Nano research  |d [Erscheinungsort nicht ermittelbar] : Tsinghua University Press, 2008  |g 9(2016), 5, Seite 1319-1333  |h Online-Ressource  |w (DE-627)57375361X  |w (DE-600)2442216-2  |w (DE-576)306837110  |x 1998-0000  |7 nnas  |a In vivo evaluation of riboflavin receptor targeted fluorescent USPIO in mice with prostate cancer xenografts 
773 1 8 |g volume:9  |g year:2016  |g number:5  |g pages:1319-1333  |g extent:15  |a In vivo evaluation of riboflavin receptor targeted fluorescent USPIO in mice with prostate cancer xenografts 
856 4 0 |u https://doi.org/10.1007/s12274-016-1028-7  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200430 
993 |a Article 
994 |a 2016 
998 |g 122976843  |a Comba, Peter  |m 122976843:Comba, Peter  |d 120000  |d 120200  |e 120000PC122976843  |e 120200PC122976843  |k 0/120000/  |k 1/120000/120200/  |p 6 
999 |a KXP-PPN1696979277  |e 3646620919 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"29 September 2016","dateIssuedKey":"2016"}],"id":{"doi":["10.1007/s12274-016-1028-7"],"eki":["1696979277"]},"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"language":["eng"],"id":{"eki":["57375361X"],"zdb":["2442216-2"],"issn":["1998-0000"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisherPlace":"[Erscheinungsort nicht ermittelbar] ; New York, NY [u.a.]","dateIssuedDisp":"2008-","dateIssuedKey":"2008","publisher":"Tsinghua University Press ; Springer"}],"part":{"issue":"5","year":"2016","extent":"15","pages":"1319-1333","text":"9(2016), 5, Seite 1319-1333","volume":"9"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Nano research","title":"Nano research"}],"disp":"In vivo evaluation of riboflavin receptor targeted fluorescent USPIO in mice with prostate cancer xenograftsNano research","pubHistory":["1.2008 -"],"recId":"57375361X","note":["Gesehen am 24.02.14"]}],"person":[{"role":"aut","family":"Jayapaul","display":"Jayapaul, Jabadurai","given":"Jabadurai"},{"role":"aut","given":"Susanne","family":"Arns","display":"Arns, Susanne"},{"role":"aut","display":"Bunker, Matt","family":"Bunker","given":"Matt"},{"family":"Weiler","display":"Weiler, Marek","given":"Marek","role":"aut"},{"given":"Sandra","display":"Rutherford, Sandra","family":"Rutherford","role":"aut"},{"family":"Comba","display":"Comba, Peter","given":"Peter","role":"aut"},{"family":"Kiessling","display":"Kiessling, Fabian","given":"Fabian","role":"aut"}],"physDesc":[{"extent":"15 S.","noteIll":"Illustrationen"}],"title":[{"title":"In vivo evaluation of riboflavin receptor targeted fluorescent USPIO in mice with prostate cancer xenografts","title_sort":"In vivo evaluation of riboflavin receptor targeted fluorescent USPIO in mice with prostate cancer xenografts"}],"note":["Gesehen am 30.04.2020"],"recId":"1696979277","name":{"displayForm":["Jabadurai Jayapaul, Susanne Arns, Matt Bunker, Marek Weiler, Sandra Rutherford, Peter Comba and Fabian Kiessling"]}} 
SRT |a JAYAPAULJAINVIVOEVAL2920